Albert, don't panic, he's just stopped posting on this particular thread.
No doubt he'll still have a read.
So to clarify my position in querying your posts, boiler, I just wanted to make it clear to others that by choosing patients in complete remission doesn't give CVac an unfair advantage in terms of trial results. Nor will it make results from Dubai any less impressive.
Also, your previous belief (that phase 2 must have had promising result for phase 3 to be approved) changed based on that article (stating an element of phase 2 is being repeated in CANVAS).
The fact that phase 3 was approved for trial hasn't changed, that should still give you confidence.
Why would they approve phase 3 if they thought the results didn't warrant it?
Albert, don't panic, he's just stopped posting on this...
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
43.5¢ |
Change
0.015(3.57%) |
Mkt cap ! $619.6M | |||
| Open | High | Low | Value | Volume |
| 41.5¢ | 44.0¢ | 41.5¢ | $1.416M | 3.301M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 38735 | 42.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 43.5¢ | 41215 | 1 |
View Market Depth
| Last trade - 16.10pm 26/06/2024 (20 minute delay) ? |
| IMM (ASX) Chart |